Application of sepsis-3 criteria to Korean patients with critical illnesses

Article information

Acute Crit Care. 2019;34(2):172-172
Publication date (electronic) : 2019 April 2
doi : https://doi.org/10.4266/acc.2018.00318.e1
1Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Hallym University Medical Center, Anyang, Korea
3Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
4Department of Anesthesiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea
5Department of Internal Medicine, St. Paul’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
6Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
7Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Busan, Korea
8Department of Anesthesia and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea
9Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Korea
10Department of Software Convergence, Seoul Women’s University, Seoul, Korea
11Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
*The first two authors contributed equally to this study.

2019 February 34(1):30-37 / https://doi.org/10.4266/acc.2018.00318

Erratum: Correction of Figure

We found an error in this article. Figure 2 was published incorrectly. In the legends of the figure, SOFA and qSOFA should be green and blue lines, respectively. The correct figure is as following.

Figure 2.

Area under the receiver operating characteristic curves (AUROCs) for discriminatory capacity for 28-day mortality and ICU mortality. (A) Twenty-eight–day mortality. AUROC: SOFA, 0.74 (95% CI, 0.68 to 0.79); qSOFA, 0.59 (95% CI, 0.53 to 0.66); SIRS, 0.60 (95% CI, 0.54 to 0.66). (B) ICU mortality. AUROC: SOFA, 0.74 (95% CI, 0.68 to 081); qSOFA, 0.59 (95% CI, 0.52 to 0.66); SIRS, 0.63 (95% CI, 0.57 to 0.70). SOFA: Sequential Organ Failure Assessment; qSOFA: quick SOFA; SIRS: systemic inflammatory response syndrome; CI: confidence interval; ICU: intensive care unit.

We apologize for any inconvenience that this may have caused.

Article information Continued

Figure 2.

Area under the receiver operating characteristic curves (AUROCs) for discriminatory capacity for 28-day mortality and ICU mortality. (A) Twenty-eight–day mortality. AUROC: SOFA, 0.74 (95% CI, 0.68 to 0.79); qSOFA, 0.59 (95% CI, 0.53 to 0.66); SIRS, 0.60 (95% CI, 0.54 to 0.66). (B) ICU mortality. AUROC: SOFA, 0.74 (95% CI, 0.68 to 081); qSOFA, 0.59 (95% CI, 0.52 to 0.66); SIRS, 0.63 (95% CI, 0.57 to 0.70). SOFA: Sequential Organ Failure Assessment; qSOFA: quick SOFA; SIRS: systemic inflammatory response syndrome; CI: confidence interval; ICU: intensive care unit.